Hot Features
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid t... CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0001 | 0.961538461538 | 0.0104 | 0.0119 | 0.0101 | 391735 | 0.01092755 | CS |
| 4 | -0.0034 | -24.4604316547 | 0.0139 | 0.0175 | 0.007 | 870090 | 0.01065818 | CS |
| 12 | -0.0205 | -66.1290322581 | 0.031 | 0.0399 | 0.007 | 868871 | 0.01870299 | CS |
| 26 | -0.0445 | -80.9090909091 | 0.055 | 0.066 | 0.007 | 684374 | 0.02759104 | CS |
| 52 | -0.0595 | -85 | 0.07 | 0.2089 | 0.007 | 734152 | 0.04823843 | CS |
| 156 | -0.0595 | -85 | 0.07 | 0.2089 | 0.007 | 734152 | 0.04823843 | CS |
| 260 | -0.0595 | -85 | 0.07 | 0.2089 | 0.007 | 734152 | 0.04823843 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.